NO20030918L - Trisykliske antitumorforbindelser som er farnesylproteintransferaseinhibitorer - Google Patents

Trisykliske antitumorforbindelser som er farnesylproteintransferaseinhibitorer

Info

Publication number
NO20030918L
NO20030918L NO20030918A NO20030918A NO20030918L NO 20030918 L NO20030918 L NO 20030918L NO 20030918 A NO20030918 A NO 20030918A NO 20030918 A NO20030918 A NO 20030918A NO 20030918 L NO20030918 L NO 20030918L
Authority
NO
Norway
Prior art keywords
protein transferase
transferase inhibitors
farnesyl protein
antitumor compounds
tricyclic
Prior art date
Application number
NO20030918A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030918D0 (no
Inventor
F George Njoroge
Bancha Vibulbhan
Alan Bruce Cooper
Timothy Guzi
Dinanath F Rane
Keith P Minor
Ronald J Doll
Viyyoor Moopil Girijavallabhan
Bama Santhanam
Patrick A Pinto
Hugh Y Zhu
Kartik M Keertikar
Carmen S Alvarez
Walter Robert Bishop
James J S Wang
Jagdish A Desai
John J Baldwin
Ge Li
Chia-Yu Huang
Ray A James
Original Assignee
Pharmacopeia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacopeia Inc filed Critical Pharmacopeia Inc
Publication of NO20030918D0 publication Critical patent/NO20030918D0/no
Publication of NO20030918L publication Critical patent/NO20030918L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/16Ring systems of three rings containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20030918A 2000-08-30 2003-02-27 Trisykliske antitumorforbindelser som er farnesylproteintransferaseinhibitorer NO20030918L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22918300P 2000-08-30 2000-08-30
PCT/US2001/026792 WO2002018368A1 (en) 2000-08-30 2001-08-28 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors

Publications (2)

Publication Number Publication Date
NO20030918D0 NO20030918D0 (no) 2003-02-27
NO20030918L true NO20030918L (no) 2003-04-29

Family

ID=22860141

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030918A NO20030918L (no) 2000-08-30 2003-02-27 Trisykliske antitumorforbindelser som er farnesylproteintransferaseinhibitorer

Country Status (27)

Country Link
US (1) US20020198216A1 (es)
EP (1) EP1313725B1 (es)
JP (1) JP2004513885A (es)
KR (1) KR20030034161A (es)
CN (1) CN100384837C (es)
AR (1) AR033680A1 (es)
AT (1) ATE359281T1 (es)
AU (2) AU2001288451C1 (es)
BR (1) BR0113675A (es)
CA (1) CA2420673A1 (es)
CO (1) CO5640109A2 (es)
DE (1) DE60127846T2 (es)
EC (1) ECSP034494A (es)
ES (1) ES2284686T3 (es)
HK (1) HK1054548B (es)
HU (1) HUP0302942A3 (es)
IL (1) IL154528A0 (es)
MX (1) MXPA03001849A (es)
NO (1) NO20030918L (es)
NZ (1) NZ524246A (es)
PE (1) PE20020486A1 (es)
PL (1) PL361103A1 (es)
RU (1) RU2293734C9 (es)
SK (1) SK2292003A3 (es)
TW (1) TWI268280B (es)
WO (1) WO2002018368A1 (es)
ZA (1) ZA200301545B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
CZ305799B6 (cs) * 2001-03-14 2016-03-23 Bristol-Myers Squibb Company Kombinace analogů epothilonu a chemoterapeutických činidel pro léčení proliferačních nemocí
AU2002340139A1 (en) * 2001-10-09 2003-04-22 The University Of Cincinnati Inhibitors of the egf receptor for the treatment of thyroid cancer
CN101181269A (zh) * 2001-11-30 2008-05-21 先灵公司 法尼基蛋白转移酶抑制剂和其它抗肿瘤剂联合使用在制备抗癌症的药物中的应用
CA2468996A1 (en) * 2001-12-03 2003-06-12 Schering Corporation Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
US20030195192A1 (en) * 2002-04-05 2003-10-16 Fortuna Haviv Nicotinamides having antiangiogenic activity
US20040014744A1 (en) * 2002-04-05 2004-01-22 Fortuna Haviv Substituted pyridines having antiangiogenic activity
EP1613308A4 (en) 2003-03-27 2008-02-20 Lankenau Inst Medical Res CANCER TREATMENT METHODS
CA2525987A1 (en) * 2003-06-05 2005-01-06 Charles Achkar Methods of treating hyperproliferative cell disorders
RU2431500C2 (ru) * 2003-06-09 2011-10-20 Самуэль ВАКСАЛ Способ ингибирования рецепторных тирозинкиназ с помощью внеклеточного антагониста и внутриклеточного антагониста
JP2007501791A (ja) 2003-08-07 2007-02-01 シェーリング コーポレイション 抗癌剤としての新規ファルネシルタンパク質トランスフェラーゼ阻害剤
US7592466B2 (en) 2003-10-09 2009-09-22 Abbott Laboratories Ureas having antiangiogenic activity
CA2591705A1 (en) * 2004-12-21 2006-06-29 Schering Corporation Novel farnesyl protein transferase inhibitors as antitumor agents
EP2313091A4 (en) * 2008-07-14 2012-04-04 Univ Kingston PHARMACEUTICAL COMPOSITIONS WITH RET-HEMMERN AND METHOD FOR THE TREATMENT OF CANCER

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
PE92098A1 (es) * 1996-07-31 1998-12-31 Schering Corp N-cianoiminas triciclicas utiles como inhibidores de transferasa de proteina farnesilo
US6071907A (en) * 1996-09-13 2000-06-06 Schering Corporation Tricyclic compounds useful as FPT inhibitors
US5925648A (en) * 1997-07-29 1999-07-20 Schering Corporation Tricyclic N-cyanoimines useful as inhibitors of a farnesyl-protein transferase
PL348294A1 (en) * 1998-12-18 2002-05-20 Schering Corp Farnesyl protein transferase inhibitors

Also Published As

Publication number Publication date
AU2001288451C1 (en) 2008-03-06
DE60127846D1 (en) 2007-05-24
TWI268280B (en) 2006-12-11
HK1054548A1 (en) 2003-12-05
CO5640109A2 (es) 2006-05-31
PL361103A1 (en) 2004-09-20
ECSP034494A (es) 2003-04-25
JP2004513885A (ja) 2004-05-13
PE20020486A1 (es) 2002-06-14
EP1313725A1 (en) 2003-05-28
AU2001288451B2 (en) 2007-05-24
HUP0302942A3 (en) 2007-02-28
IL154528A0 (en) 2003-09-17
MXPA03001849A (es) 2003-06-04
WO2002018368A1 (en) 2002-03-07
BR0113675A (pt) 2003-06-24
RU2293734C2 (ru) 2007-02-20
ES2284686T3 (es) 2007-11-16
CN1471524A (zh) 2004-01-28
HK1054548B (zh) 2007-10-18
ATE359281T1 (de) 2007-05-15
RU2293734C9 (ru) 2007-10-10
DE60127846T2 (de) 2008-03-06
AU8845101A (en) 2002-03-13
NO20030918D0 (no) 2003-02-27
CN100384837C (zh) 2008-04-30
SK2292003A3 (en) 2003-08-05
CA2420673A1 (en) 2002-03-07
KR20030034161A (ko) 2003-05-01
AR033680A1 (es) 2004-01-07
HUP0302942A2 (hu) 2003-12-29
ZA200301545B (en) 2004-06-22
US20020198216A1 (en) 2002-12-26
NZ524246A (en) 2004-11-26
EP1313725B1 (en) 2007-04-11

Similar Documents

Publication Publication Date Title
HK1087122A1 (en) Novel farnesyl protein transferase inhibitors as antitumor agents
AU2001246477A1 (en) Farnesyl protein transferase inhibitor combinations with platinum compounds
NO20030779D0 (no) Kondenserte pyrazolderivater som er proteinkinase-inhibitorer
NO20024950D0 (no) 4-Merkaptopyrrolidinderivater som farnesyltransferaseinhibitorer
AU2001240658A1 (en) Farnesyl protein transferase inhibitor combinations with camptothecin compounds
NO20030918D0 (no) Trisykliske antitumorforbindelser som er farnesylproteintransferaseinhibitorer
ATE293622T1 (de) Farnesyl protein transferase inhibitoren
AU2001239275A1 (en) Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives
DE60101323D1 (de) Tricyclische proteinkinasehemmer
NO20044053L (no) Farnesylproteintransferaseinhibitorer som antitumormidler
AU2001252147A1 (en) Farnesyl protein transferase inhibitor combinations
DK1339695T3 (da) Farnesyltransferase-inhibitorer
NO20012961D0 (no) Trisykliske farnesylproteintransferase-inhibitorer
IS6358A (is) Farnasýl transferasa latar
ZA200705126B (en) Novel farnesyl protein transferase inhibitors as antitumor agents
AU3514302A (en) 0ovel farnesyl protein transferase inhibitors
NO20022923D0 (no) Inhibitorer av farnesyl-protein-transferase

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application